Charles Neral - CLARIVATE PLC Independent Director
| CLVT Stock | USD 5.76 0.18 3.23% |
Insider
Charles Neral is Independent Director of CLARIVATE PLC since 2019.
| Age | 61 |
| Tenure | 5 years |
| Address | 70 St. Mary Axe, London, United Kingdom, EC3A 8BE |
| Phone | 44 20 7433 4000 |
| Web | https://www.clarivate.com |
CLARIVATE PLC Management Efficiency
The company has return on total asset (ROA) of 0.013 % which means that it generated a profit of $0.013 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2114) %, meaning that it created substantial loss on money invested by shareholders. CLARIVATE PLC's management efficiency ratios could be used to measure how well CLARIVATE PLC manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.57 in 2024. Return On Capital Employed is likely to drop to -0.07 in 2024. Total Current Liabilities is likely to drop to about 1 B in 2024. Liabilities And Stockholders Equity is likely to drop to about 12.4 B in 2024Similar Executives
| Showing other executives | INSIDER Age | ||
| Yvonne Genovese | Gartner | 58 | |
| James Shappell | Parsons Corp | N/A | |
| Alan Dunning | WNS Holdings | 67 | |
| Diana Ferguson | Gartner | 57 | |
| Todd Probert | CACI International | 57 | |
| Steve Cook | Leidos Holdings | N/A | |
| Travis Johnson | CACI International | 39 | |
| Suhrid Brahma | WNS Holdings | 53 | |
| Akhil Jain | Gartner | 42 | |
| Jeffrey MacLauchlan | CACI International | 65 | |
| Michael Kolloway | Parsons Corp | 63 | |
| Robin Palmer | ASGN Inc | N/A | |
| Vidya Rao | Genpact Limited | N/A | |
| Harry McMahon | Parsons Corp | 67 | |
| Suzanne Vautrinot | Parsons Corp | 61 | |
| Carol Lindstrom | ASGN Inc | 66 | |
| Jason Yaley | Parsons Corp | N/A | |
| Maureen Waterston | Leidos Holdings | 59 | |
| Robert Genter | Science Applications Internatio | 48 | |
| Mark Holdsworth | Parsons Corp | 55 | |
| Randy Phillips | Leidos Holdings | 65 | |
Management Performance
| Return On Equity | -0.21 | ||||
| Return On Asset | 0.013 |
CLARIVATE PLC Leadership Team
Elected by the shareholders, the CLARIVATE PLC's board of directors comprises two types of representatives: CLARIVATE PLC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CLARIVATE. The board's role is to monitor CLARIVATE PLC's management team and ensure that shareholders' interests are well served. CLARIVATE PLC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CLARIVATE PLC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Melanie JD, Chief Secretary | ||
| Michael Easton, Senior Vice President - Finance, Chief Accounting Officer | ||
| Jaspal Chahal, Chief Legal Officer, General Counsel | ||
| Ed Mattix, Chief Officer | ||
| Stefano Maestri, Chief Officer | ||
| William Graff, Executive Officer | ||
| Mark Donohue, Head Relations | ||
| Anthony Munk, Lead Independent Director | ||
| Kosty Gilis, Independent Director | ||
| Matti Tov, CEO Director | ||
| Henry Levy, President Healthcare | ||
| Andrew Snyder, Vice Chairman of the Board | ||
| Gordon Samson, President IP Group | ||
| Michael Angelakis, Director | ||
| Charles Neral, Independent Director | ||
| Julie Wilson, Chief People Officer | ||
| Richard Finch, Global Services | ||
| Steen Lomholtthomsen, Chief Revenue Officer | ||
| Sheryl Blucher, Independent Director | ||
| Jonathan Collins, Chief Financial Officer, Executive Vice President | ||
| Jonathan Gear, CEO Director | ||
| Tabita Andersson, Senior Brand | ||
| Mukhtar Ahmed, President Science Group | ||
| Melanie Fitzpatrick, Executive Transformation | ||
| Usama Cortas, Independent Director | ||
| Julia Wilson, Chief Officer | ||
| Richard Hanks, Chief Financial Officer | ||
| Richard Roedel, Independent Director | ||
| Nicholas Macksey, Independent Director | ||
| Mark CPA, Head Relations | ||
| Bar Veinstein, President Government | ||
| Jerre Stead, Executive Chairman of the Board, Chief Executive Officer | ||
| Jane Bomba, Independent Director | ||
| Balakrishnan Iyer, Independent Director |
CLARIVATE Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CLARIVATE PLC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.21 | ||||
| Return On Asset | 0.013 | ||||
| Profit Margin | (0.50) % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 8.29 B | ||||
| Shares Outstanding | 710.4 M | ||||
| Shares Owned By Insiders | 15.84 % | ||||
| Shares Owned By Institutions | 91.70 % | ||||
| Number Of Shares Shorted | 35.93 M | ||||
| Price To Book | 0.72 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for CLARIVATE Stock Analysis
When running CLARIVATE PLC's price analysis, check to measure CLARIVATE PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CLARIVATE PLC is operating at the current time. Most of CLARIVATE PLC's value examination focuses on studying past and present price action to predict the probability of CLARIVATE PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CLARIVATE PLC's price. Additionally, you may evaluate how the addition of CLARIVATE PLC to your portfolios can decrease your overall portfolio volatility.